• Home
      • StockReports™Analyse your stocks in seconds
      • Stock ResearchExpert insight you can understand
      • StockRanks™Identify winning stocks
      • ScreenersGenerate investing ideas fast
      • PortfoliosMonitor and improve your performance
      • Charts and toolsTime your trades better
      • Academy
        • All topics
        • Analyse stocks
        • Discover stocks
        • Investment strategy
        • Portfolio management
      • Additional resources
        • Events
        • Product guides
        • Ratio glossary
        • Newsletter
        • Companies & markets
    • Reviews
    • Pricing
    • About
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchMydecine Innovations
    Picture of Mydecine Innovations logo

    MYCOF — Mydecine Innovations Share News

    $0.010.000.00%
    us flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapSucker Stock
    • Market Cap
      $0.23m
    • Enterprise Value
      $4.99m
    • Revenue
    • Quality
      3
    • Value
      1
    • Momentum
      45
    • StockRank™
      5
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • MYCOF Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    MYCOF Dividends
    • REG-Mydecine Innovations Group Inc: Mydecine Innovations Group Receives Two Notice of Allowances from USPTO for its MYCO-005 and MYCO-006 Family of Compounds

      08/02/2024 07:15Announcement
    • REG-Mydecine Innovations Group Inc: Mydecine Innovations Group Announces Director Resignation

      02/02/2024 07:15Announcement
    • REG-Mydecine Innovations Group Inc: Mydecine Innovations Group Receives Notice of Allowance from USPTO for its MYCO-005 Compound

      18/12/2023 07:15Announcement
    • REG-Mydecine Innovations Group Inc: MYDECINE INNOVATIONS GROUP FILES PROSPECTUS SUPPLEMENT, ANNOUNCES CLOSING UNDER SHARE SUBSCRIPTION AGREEMENTS

      31/10/2023 07:15Announcement
    • REG-Mydecine Innovations Group Inc: Q4 2023 Business Update

      26/10/2023 07:15Announcement
    • REG-Mydecine Innovations Group Inc: Mydecine Innovations Group Announces Admission to Trading on the AQSE Growth Market in London, UK

      13/10/2023 18:15Announcement
    Previous12Next

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2025, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.